Spectral AI (MDAI) Net Cash Flow Growth (1y) (2022 - 2026)
Spectral AI (MDAI) Net Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.74 Bn | 194.14 Bn | 7.27 Bn | -562.77% |
| 2 | Stryker | 129.74 Bn | 126.26 Bn | 4.50 Bn | 2,827.78% |
| 3 | Medtronic | 119.78 Bn | 110.56 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 73.98 Bn | 73.44 Bn | 3.85 Bn | -395.56% |
| 5 | Edwards Lifesciences | 52.45 Bn | 48.19 Bn | 1.35 Bn | 168.38% |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | -103.49% |
| 7 | GE HealthCare Technologies | 34.12 Bn | 32.01 Bn | 2.18 Bn | -114.85% |
| 8 | Koninklijke Philips | 26.41 Bn | 23.09 Bn | 4.55 Bn | -215.59% |
| 9 | Steris | 23.26 Bn | 22.77 Bn | 684.20 Mn | -54.17% |
| 10 | Spectral AI | 50.69 Mn | 36.69 Mn | 1.11 Mn | 165.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 165.17% |
| Mar 31, 2026 | -141.96% |
| Dec 31, 2025 | 231.62% |
| Sep 30, 2025 | 99.50% |
| Jun 30, 2025 | -8.81% |
| Mar 31, 2025 | 65.52% |
| Dec 31, 2024 | 157.47% |
| Sep 30, 2024 | -289.98% |
| Jun 30, 2024 | -52.63% |
| Mar 31, 2024 | 239.13% |
| Dec 31, 2023 | -101.02% |
| Sep 30, 2023 | -156.18% |
| Jun 30, 2023 | -794.77% |
| Mar 31, 2023 | -1,171.44% |
| Dec 31, 2022 | 265,918.08% |
| Sep 30, 2022 | -6,392.72% |
| Jun 30, 2022 | 68.11% |
| Mar 31, 2022 | -118.71% |